Nkarta to Participate at Upcoming Investor Conference
SOUTH SAN FRANCISCO, Calif., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, today announced its participation at this upcoming investor conference:
Cantor Virtual Global Healthcare Conference
A simultaneous webcast of the presentation will be available on the Investors section of Nkarta’s website, www.nkartatx.com, and a replay will be rchived on the website for approximately four weeks.
Nkarta Media/Investor Contact:
Compliance is King (to your Opportunities and Profits!)
Asset Management â€“ Keeping Remote Devices Connected
IoT Evolution Expo #TECHSUPERSHOW Expo Hall Open